Elon Musk’s Neuralink may have just secured $205 million in Series C funding, but there’s another brain-computer interface in the news that is pulling ahead in the race to market. According to a recent Bloomberg Quint article, New York-based Synchron Inc. received the FDA’s green light to begin human trials to determine if their implants work safely and could eventually be sold in the U. S.
This Brain Computer Startup Beat Neuralink to FDA Trials
The announcement moves Synchron Inc. ahead of Elon Musk’s company in the race to market.
Aug 6, 2021
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER FOR $30!